214 related articles for article (PubMed ID: 20303627)
21. Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?
Iurlo A; Cattaneo D
Blood Rev; 2023 Mar; 58():101014. PubMed ID: 36153195
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes.
Dispenza MC; Bochner BS
Curr Hematol Malig Rep; 2018 Jun; 13(3):191-201. PubMed ID: 29680938
[TBL] [Abstract][Full Text] [Related]
23. Advances in diagnosis and treatment of eosinophilia.
Sheikh J; Weller PF
Curr Opin Hematol; 2009 Jan; 16(1):3-8. PubMed ID: 19057198
[TBL] [Abstract][Full Text] [Related]
24. [Hematological disorders and hypereosinophilias].
Malfuson JV; Fagot T; Konopacki J; Mangouka L; Souleau B; de Revel T
Rev Med Interne; 2009 Apr; 30(4):322-30. PubMed ID: 19201511
[TBL] [Abstract][Full Text] [Related]
25. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
Moles MP; Landry J; Roche-Lestienne C; Godon A; Schmidt-Tanguy A; Gardembas M; Le Clech C; Verret JL; Zandecki M; Blanchet O
Ann Biol Clin (Paris); 2005; 63(3):317-22. PubMed ID: 15951264
[TBL] [Abstract][Full Text] [Related]
26. A case of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia with a rare FIP1L1 breakpoint.
Lambert F; Heimann P; Herens C; Chariot A; Bours V
J Mol Diagn; 2007 Jul; 9(3):414-9. PubMed ID: 17591942
[TBL] [Abstract][Full Text] [Related]
27. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
[TBL] [Abstract][Full Text] [Related]
28. Current concepts on the pathogenesis of the hypereosinophilic syndrome/chronic eosinophilic leukemia.
Yamada Y; Rothenberg ME; Cancelas JA
Transl Oncogenomics; 2006; 1():53-63. PubMed ID: 23662039
[TBL] [Abstract][Full Text] [Related]
29. Novel therapies for hypereosinophilic syndromes.
Antoniu SA
Neth J Med; 2010 Aug; 68(1):304-10. PubMed ID: 20739727
[TBL] [Abstract][Full Text] [Related]
30. Advances in the diagnosis and treatment of eosinophilia.
Helbig G
Curr Opin Hematol; 2014 Jan; 21(1):3-7. PubMed ID: 24322486
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic options for patients with clonal and idiopathic hypereosinophia.
Quintás-Cardama A; Cortes J
Expert Opin Investig Drugs; 2008 Jul; 17(7):1039-50. PubMed ID: 18549340
[TBL] [Abstract][Full Text] [Related]
32. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
Valent P; Degenfeld-Schonburg L; Sadovnik I; Horny HP; Arock M; Simon HU; Reiter A; Bochner BS
Semin Immunopathol; 2021 Jun; 43(3):423-438. PubMed ID: 34052871
[TBL] [Abstract][Full Text] [Related]
33. Hypereosinophilic syndrome: an update.
Wilkins HJ; Crane MM; Copeland K; Williams WV
Am J Hematol; 2005 Oct; 80(2):148-57. PubMed ID: 16184589
[TBL] [Abstract][Full Text] [Related]
34. FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.
Wang LN; Pan Q; Fu JF; Shi JY; Jin J; Li JM; Hu J; Zhao WL; Chen Z; Chen SJ
Chin Med J (Engl); 2008 May; 121(10):867-73. PubMed ID: 18706197
[TBL] [Abstract][Full Text] [Related]
35. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2011 Aug; 86(8):677-88. PubMed ID: 21761433
[TBL] [Abstract][Full Text] [Related]
36. World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2012 Sep; 87(9):903-14. PubMed ID: 22926771
[TBL] [Abstract][Full Text] [Related]
37. [The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia].
Chrobák L; Voglová J
Vnitr Lek; 2005 Dec; 51(12):1385-93. PubMed ID: 16430106
[TBL] [Abstract][Full Text] [Related]
38. Lymphocytic variant hypereosinophilic syndromes.
Roufosse F; Cogan E; Goldman M
Immunol Allergy Clin North Am; 2007 Aug; 27(3):389-413. PubMed ID: 17868856
[TBL] [Abstract][Full Text] [Related]
39. The Spectrum of Hypereosinophilia and Associated Clonal Disorders - A Real-World Data Based on Combined Retrospective and Prospective Analysis from a Tropical Setting.
Sreedharanunni S; Varma N; Sachdeva MUS; Naseem S; Malhotra P; Bansal D; Trehan A; Varma S
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018052. PubMed ID: 30210745
[TBL] [Abstract][Full Text] [Related]
40. Hypereosinophilic syndrome: current approach to diagnosis and treatment.
Klion A
Annu Rev Med; 2009; 60():293-306. PubMed ID: 19630574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
